Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Molecular Therapy. Oncology|April 21, 2025
Shared neoantigens for cancer immunotherapyAnastasia Goloudina, Fabien Le Chevalier, Pierre Authié, et al.Communications Biology|June 11, 2021
Lentiviral vector induces high-quality memory T cells via dendritic cells transductionMin Wen Ku, Pierre Authié, Fabien Nevo, et al.Frontiers in Immunology|September 1, 2023
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue virusesKirill Nemirov, Pierre Authié, Philippe Souque, et al.NPJ Vaccines|July 4, 2025
Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneityBenjamin Vesin, Ingrid Fert, Amandine Noirat, et al.Vaccine|August 3, 2025
Lentiviral vector-based T-cell vaccines against Zika and yellow fever virusesPierre Authié, Philippe Souque, Fanny Moncoq, et al.Scientific Reports|July 2, 2025
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapyAnastasia Goloudina, Fabien Le Chevalier, Pierre Authié, et al.NPJ Vaccines|June 10, 2024
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vectorIngrid Fert, Laëtitia Douguet, Benjamin Vesin, et al.Cell Reports|July 29, 2022
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunityJodie Lopez, François Anna, Pierre Authié, et al.EMBO Molecular Medicine|September 7, 2023
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccineLaëtitia Douguet, Ingrid Fert, Jodie Lopez, et al.Vaccines|January 21, 2023
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden HamstersBenjamin Vesin, Pierre Authié, Catherine Blanc, et al.Pageof 2